TotalMarketCap

Rezolute

RZLTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$354.511 M

$3.67 -7.45%

Close of 6 Nov 2026

As of 6 Nov 2026, Rezolute (RZLT) has a market capitalization of $354.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$74.4M

Loss-making

Shares outstanding

96,722,333

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #210Lyell ImmunopharmaLYEL$360.9M
  2. #211Avalo TherapeuticsAVTX$355.6M
  3. #212RezoluteRZLT$354.5M
  4. #213Contineum TherapeuticsCTNM$353.2M
  5. #214Atea PharmaceuticalsAVIR$338.9M

What if Rezolute were worth as much as…

Open the what-if tool →

Gold $28.2T

$291,917.62

Per share 79,650× higher

Bitcoin $1.53T

$15,795.15

Per share 4,310× higher

Apple $5.02T

$51,854.02

Per share 14,148× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Rezolute are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.